| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product name | Acalabrutinib |
| Cas No. | 1420477-60-6 |
| Molecular Formula | C26H23N7O2 |
| Appearance | White crystalline powder |
Acalabrutinib, also known as ACP-196, is an orally available Bruton tyrosine kinase (BTK) inhibitor with potential antitumor activity.When applied, ACP-196 inhibits BTK activity and blocks activation of the B cell antigen receptor (BCR) signaling pathway.This prevents B cell activation and BTK-mediated activation of downstream survival pathways.
This leads to inhibition of the growth of malignant B cells that overexpress BTK.BTK is a member of the Src associated BTK/TEC cytoplasmic tyrosine kinase family and is overexpressed in B-cell malignancies.It plays an important role in B lymphocyte development, activation, signaling, proliferation, and survival.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}